Stay updated on Presendin in IIH Study: Clinical Trial
Sign up to get notified when there's something new on the Presendin in IIH Study: Clinical Trial page.

Latest updates to the Presendin in IIH Study: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded multiple study locations across the US and Australia (Colorado, Florida, Minnesota, New York, Tennessee, Texas, New South Wales, South Australia, Victoria) and removed the prior individual location headers. The page revision is updated from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedPremier Research added and revision updated to v3.3.2; Premier Research Group plc removed and revision updated to v3.2.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedDeleted the government funding lapse notice banner from the page; the trial details and eligibility information remain unchanged.SummaryDifference0.3%

- Check63 days agoChange DetectedThe IIH EVOLVE trial NCT05347147 has been terminated following a strategic evaluation. The study record now reflects termination and updated study dates.SummaryDifference0.4%

- Check91 days agoChange DetectedAdds a government operating status notice and a v3.2.0 revision tag; removes the specific resource Benign intracranial hypertension (v3.1.0).SummaryDifference2%

- Check98 days agoChange DetectedSummary of changes: updated the revision from v3.0.2 to v3.1.0 and added a new topic (Benign intracranial hypertension); several MedlinePlus topic deletions were removed from the page.SummaryDifference0.5%

Stay in the know with updates to Presendin in IIH Study: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Presendin in IIH Study: Clinical Trial page.